Hogy Medical Co.,Ltd. (TYO:3593)
Japan · Delayed Price · Currency is JPY 6,690.00
+10.00 (0.15%)
Jan 23, 2026, 3:30 PM JST
Hogy Medical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 38,376 | 39,138 | 39,100 | 38,981 | 36,778 | 36,504 | Upgrade | |
Revenue Growth (YoY) | -2.06% | 0.10% | 0.30% | 5.99% | 0.75% | -1.96% | Upgrade |
Cost of Revenue | 25,881 | 26,517 | 26,037 | 23,241 | 21,361 | 21,177 | Upgrade |
Gross Profit | 12,495 | 12,621 | 13,063 | 15,740 | 15,417 | 15,327 | Upgrade |
Selling, General & Admin | 8,968 | 8,288 | 8,322 | 8,436 | 8,476 | 8,788 | Upgrade |
Operating Expenses | 9,512 | 8,993 | 8,894 | 9,105 | 9,281 | 9,694 | Upgrade |
Operating Income | 2,983 | 3,628 | 4,169 | 6,635 | 6,136 | 5,633 | Upgrade |
Interest Expense | -102 | -70 | -23 | -29 | -6 | -2 | Upgrade |
Interest & Investment Income | 236 | 285 | 307 | 155 | 84 | 123 | Upgrade |
Currency Exchange Gain (Loss) | -79 | 33 | -37 | - | -43 | 10 | Upgrade |
Other Non Operating Income (Expenses) | -291 | -232 | -171 | -108 | 115 | 223 | Upgrade |
EBT Excluding Unusual Items | 2,747 | 3,644 | 4,245 | 6,653 | 6,286 | 5,987 | Upgrade |
Gain (Loss) on Sale of Investments | -1,266 | -169 | - | - | - | 1,028 | Upgrade |
Gain (Loss) on Sale of Assets | 98 | -6 | 40 | - | 1 | 1 | Upgrade |
Asset Writedown | -2 | -533 | -209 | -464 | -1 | -28 | Upgrade |
Other Unusual Items | -3 | -3 | -1 | - | - | 1 | Upgrade |
Pretax Income | 1,574 | 2,933 | 4,075 | 6,189 | 6,286 | 6,989 | Upgrade |
Income Tax Expense | 1,014 | 1,413 | 1,282 | 1,904 | 1,951 | 2,060 | Upgrade |
Earnings From Continuing Operations | 560 | 1,520 | 2,793 | 4,285 | 4,335 | 4,929 | Upgrade |
Minority Interest in Earnings | - | - | 11 | 31 | 35 | 30 | Upgrade |
Net Income | 560 | 1,520 | 2,804 | 4,316 | 4,370 | 4,959 | Upgrade |
Net Income to Common | 560 | 1,520 | 2,804 | 4,316 | 4,370 | 4,959 | Upgrade |
Net Income Growth | -80.95% | -45.79% | -35.03% | -1.24% | -11.88% | -10.31% | Upgrade |
Shares Outstanding (Basic) | 22 | 22 | 24 | 24 | 29 | 30 | Upgrade |
Shares Outstanding (Diluted) | 22 | 22 | 24 | 24 | 29 | 30 | Upgrade |
Shares Change (YoY) | -9.12% | -7.82% | 0.04% | -15.08% | -5.52% | 0.09% | Upgrade |
EPS (Basic) | 25.97 | 67.95 | 115.54 | 177.93 | 152.99 | 164.03 | Upgrade |
EPS (Diluted) | 25.97 | 67.95 | 115.54 | 177.93 | 152.99 | 164.03 | Upgrade |
EPS Growth | -79.03% | -41.19% | -35.06% | 16.30% | -6.73% | -10.39% | Upgrade |
Free Cash Flow | 1,208 | 6,325 | 4,431 | 7,858 | 5,453 | -496 | Upgrade |
Free Cash Flow Per Share | 56.02 | 282.75 | 182.59 | 323.95 | 190.91 | -16.41 | Upgrade |
Dividend Per Share | 87.500 | 80.000 | 80.000 | 71.000 | 68.000 | 68.000 | Upgrade |
Dividend Growth | -27.08% | - | 12.68% | 4.41% | - | 3.03% | Upgrade |
Gross Margin | 32.56% | 32.25% | 33.41% | 40.38% | 41.92% | 41.99% | Upgrade |
Operating Margin | 7.77% | 9.27% | 10.66% | 17.02% | 16.68% | 15.43% | Upgrade |
Profit Margin | 1.46% | 3.88% | 7.17% | 11.07% | 11.88% | 13.58% | Upgrade |
Free Cash Flow Margin | 3.15% | 16.16% | 11.33% | 20.16% | 14.83% | -1.36% | Upgrade |
EBITDA | 8,465 | 9,369 | 10,776 | 10,252 | 10,251 | 10,182 | Upgrade |
EBITDA Margin | 22.06% | 23.94% | 27.56% | 26.30% | 27.87% | 27.89% | Upgrade |
D&A For EBITDA | 5,482 | 5,741 | 6,607 | 3,617 | 4,115 | 4,549 | Upgrade |
EBIT | 2,983 | 3,628 | 4,169 | 6,635 | 6,136 | 5,633 | Upgrade |
EBIT Margin | 7.77% | 9.27% | 10.66% | 17.02% | 16.68% | 15.43% | Upgrade |
Effective Tax Rate | 64.42% | 48.18% | 31.46% | 30.76% | 31.04% | 29.48% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.